Adiponectin and leptin serum levels in osteoporotic postmenopausal women treated with raloxifene or alendronate

Menopause

Volumn 19, Issue 2, 2012, Pages 172-177

  Sebastián Ochoa, Arántzazu ^a,b   Fernández García, Diego ^a,b   Reyes García, Rebeca ^a   Mezquita Raya, Pedro ^c   Rozas Moreno, Pedro ^a   Alonso Garcia, Guillermo ^a   Muñoz Torres, Manuel ^a  

^a HOSPITAL UNIVERSITARIO SAN CECILIO   (Spain)

^b HOSPITAL UNIVERSITARIO VIRGEN DE LA VICTORIA   (Spain)

^c HOSPITAL TORRECÁRDENAS   (Spain)

Author keywords

Adiponectin; Alendronate; Leptin; Postmenopausal osteoporosis; Raloxifene

Indexed keywords

ADIPONECTIN; ALENDRONIC ACID; ESTRADIOL; LEPTIN; RALOXIFENE;

ADULT; AGED; ARTICLE; BODY MASS; BONE DENSITY; BONE MASS; BONE TURNOVER; CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; HUMAN; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PROSPECTIVE STUDY; WAIST CIRCUMFERENCE;

ADIPONECTIN; AGED; ALENDRONATE; BODY MASS INDEX; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; LEPTIN; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL; RALOXIFENE;

EID: 84856557325     PISSN: 10723714     EISSN: 15300374     Source Type: Journal    
DOI: 10.1097/gme.0b013e31822815c0     Document Type: Article

References (28)

1. Gordeladze JO, Drevon CA, Syversen U, Reseland JE. Leptin stimulates human osteoblastic cell proliferation, de novo collagen synthesis, and mineralization: impact on differentiation markers, apoptosis, and osteoclastic signaling. J Cell Biochem 2002;85:825-836. (Pubitemid 34462792)
2. Holloway WR, Collier FM, Aitken CJ, et al. Leptin inhibits osteoclast generation. J Bone Miner Res 2002;17:200-209. (Pubitemid 34087652)
3. Blain H, Vuillemin A, Guillemin F, et al. Serum leptin level is a predictor of bone mineral density in postmenopausal women. J Clin Endocrinol Metab 2002;87:1030-1035. (Pubitemid 36121060)
4. Cakmak A, Posaci C, Dogan E, Caliskan S, Guclu S, Altunyurt S. Raloxifene increases serum leptin levels in postmenopausal women: a prospective study. Am J Obstet Gynecol 2005;193:347-351. (Pubitemid 41159525)
5. Yamauchi M, Sugimoto T, Yamaguchi T, et al. Plasma leptin concentrations are associated with bone mineral density and the presence of vertebral fractures in postmenopausal women. Clin Endocrinol (Oxf) 2001; 55:341-347. (Pubitemid 32823044)
6. Schett G, Kiechl S, Bonora E, et al. Serum leptin level and the risk of nontraumatic fracture. Am J Med 2004;117:952-956. (Pubitemid 40075564)
7. Goulding A, Taylor RW. Plasma leptin values in relation to bone mass and density and to dynamic biochemical markers of bone resorption and formation in postmenopausal women. Calcif Tissue Int 1998; 63:456-458. (Pubitemid 28531792)
8. Pasco JA, Henry MJ, Kotowicz MA, et al. Serum leptin levels are associated with bone mass in nonobese women. J Clin Endocrinol Metab 2001;86:1884-1887. (Pubitemid 32472890)
9. Ushiroyama T, Ikeda A, Hosotani T, Higashiyama T, Ueki M. Inverse correlation between serum leptin concentration and vertebral bone density in postmenopausal women. Gynecol Endocrinol 2003;17:31-36. (Pubitemid 36349879)
10. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. J Bone Miner Res 2004;19: 546-551. (Pubitemid 41071213)
11. Filip R, Raszewski G. Bone mineral density and bone turnover in relation to serum leptin, alpha ketoglutarate and sex steroids in overweight and obese postmenopausal women. Clin Endocrinol 2009;70:214-220.
12. Shinoda Y, Yamaguchi M, Ogata N, et al. Regulation of bone formation by adiponectin through autocrine/paracrine and endocrine pathways. J Cell Biochem 2006;99:196-208. (Pubitemid 44297964)
13. Ozkurt B, Ozkurt ZN, Altay M, Aktekin CN, Cálayan O, Tabak Y. The relationship between serum adiponectin level and anthropometry, bone mass, osteoporotic fracture risk in postmenopausal women. Eklem Hastalik Cerrahisi 2009;20:78-84.
14. Lee WL, Chao HT, Cheng MH, Wang PH. Rationale for using raloxifene to prevent both osteoporosis and breast cancer in postmenopausal women. Maturitas 2008;60:92-107.
15. Tommaselli GA, Di Carlo C, Di Spiezio Sardo A, et al. Serum leptin levels and body composition in postmenopausal women treated with tibolone and raloxifene. Menopause 2006;13:660-668. (Pubitemid 44079536)
16. Lambrinoudaki IV, Christodoulakos GE, Economou EV, et al. Circulating leptin and ghrelin are differentially influenced by estrogen/progestin therapy and raloxifene. Maturitas 2008;59:62-71.
17. Christodoulakos GE, Lambrinoudaki IV, Creatsa MG, et al. Circulating levels of atherogenesis-associated adipocytokines and apoptotic markers are differentially influenced by hormone therapy, tibolone and raloxifene in healthy postmenopausal women. Climacteric 2008;11:155-165. (Pubitemid 351451118)
18. Considine RV, Sinha MK, Heiman ML, et al. Serum immunoreactiveleptin concentrations in normal-weight and obese humans. N Engl J Med 1996;334:292-295. (Pubitemid 26033933)
19. Gavrila A, Chan JL, Yiannakouris N, et al. Serum adiponectin levels are inversely associated with overall and central fat distribution but are not directly regulated by acute fasting or leptin administration in humans: cross-sectional and interventional studies. J Clin Endocrinol Metab 2003;88:4823-4831. (Pubitemid 37357532)
20. Arita Y, Kihara S, Ouchi N, et al. Paradoxical decrease of an adiposespecific protein, adiponectin, in obesity. Biochem Biophys Res Commun 1999;257:79-83. (Pubitemid 29299050)
21. Oshima K, Nampei A, Matsuda M, et al. Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun 2005;331:520-526. (Pubitemid 40602668)
22. Berner HS, Lyngstaadaas SP, Spahr A, et al. Adiponectin and its receptors are expressed in bone-forming cells. Bone 2004;35:842-849. (Pubitemid 39349215)
23. Wu N, Wang QP, Li H, Wu XP, Sun ZQ, Luo XH. Relationships between serum adiponectin, leptin concentrations and bone mineral density, and bone biochemical markers in Chinese women. Clin Chim Acta 2010;411: 771-775.
24. Odabazi E, Ozata M, Turan M, et al. Plasma leptin concentrations in postmenopausal women with osteoporosis. Eur J Endocrinol 2000;142:170-173. (Pubitemid 30121031)
25. Shaarawy M, Abassi AF, Hassan H, Salem ME. Relationship between serum leptin concentrations and bone mineral density as well as biochemical markers of bone turnover in women with postmenopausal osteoporosis. Fertil Steril 2003;79:919-924. (Pubitemid 36385014)
26. Sodi R, Hazell MJ, Durham BH, Rees C, Ranganath LR, Fraser WD. The circulating concentration and ratio of total and high molecular weight adiponectin in post-menopausal women with and without osteoporosis and its association with body mass index and biochemical markers of bone metabolism. Clin Biochem 2009;42:1375-1380.
27. Araneta MR, von Mühlen D, Barrett-Connor E. Sex differences in the association between adiponectin and BMD, bone loss, and fractures: the Rancho Bernardo study. J Bone Miner Res 2009;24:2016-2022.
28. Riggs BL, Koshla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279-302. (Pubitemid 34651948)